NEW YORK (Reuters Health) - The prevalence of depression and anxiety among patients with polycystic ovary syndrome is high and warrants routine screening and aggressive treatment, investigators report in the journal Fertility and Sterility.
NEW YORK (Reuters Health) - The prevalence of depression and anxiety among patients with polycystic ovary syndrome is high and warrants routine screening and aggressive treatment, investigators report in the journal Fertility and Sterility.